Author: "Zwiener I" / Publisher: elsevier bv - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Zwiener I"' showing total 7 results

Start Over Author "Zwiener I" Publisher elsevier bv

7 results on '"Zwiener I"'

1. PATIENT PHENOTYPES AND SGLT-2 INHIBITION IN TYPE 2 DIABETES MELLITUS: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL

Author: Sharma, A., primary, Ofstad, A., additional, Ahmad, T., additional, Zinman, B., additional, Zwiener, I., additional, Fitchett, D., additional, Wanner, C., additional, George, J., additional, Hantel, S., additional, Desai, N., additional, and Mentz, R., additional
Published: 2020
Full Text: View/download PDF

2. URIC ACID LEVELS PREDICT CARDIORENAL OUTCOMES AND CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME

Author: Verma, S., primary, Qiuhe, J., additional, Bhatt, D., additional, Mazer, C., additional, Al-Omran, M., additional, Inzucchi, S., additional, Wanner, C., additional, Ofstad, A., additional, Zwiener, I., additional, George, J., additional, Zinman, B., additional, and Fitchett, D., additional
Published: 2019
Full Text: View/download PDF

3. QUALIFYING EVENT PROXIMITY, CARDIOVASCULAR RISK, AND BENEFIT OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES AND STABLE ATHEROSCLEROSIS IN THE EMPA-REG OUTCOME TRIAL

Author: Udell, J., primary, Zinman, B., additional, Wanner, C., additional, von Eynatten, M., additional, George, J., additional, Zwiener, I., additional, Lund, S., additional, Hantel, S., additional, and Fitchett, D., additional
Published: 2019
Full Text: View/download PDF

4. SAT-305 EFFECTS OF EMPAGLIFLOZIN VS PLACEBO ON CARDIORENAL OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES AND PROTEINURIC DIABETIC KIDNEY DISEASE: INSIGHTS FROM EMPA-REG OUTCOME

Author: Wanner MD, C., primary, Zinman, B., additional, von Eynatten, M., additional, Koitka-Weber, A., additional, Zwiener, I., additional, and Hauske, S.J., additional
Published: 2019
Full Text: View/download PDF

5. Qualifying Event Proximity, Cardiovascular Risk, and Benefit of Empagliflozin in Patients with Type 2 Diabetes and Stable Atherosclerosis in the EMPA-REG OUTCOME Trial

Author: D’Emden, M., primary, Udell, J., additional, Zinman, B., additional, Wanner, C., additional, von Eynatten, M., additional, George, J., additional, Zwiener, I., additional, Lund, S., additional, Hantel, S., additional, and Fitchett, D., additional
Published: 2019
Full Text: View/download PDF

6. Avelumab treatment in chemotherapy-naïve patients with distant metastatic Merkel cell carcinoma (mMCC)

Author: D'Angelo, S.P., primary, Russell, J., additional, Hassel, J., additional, Lebbé, C., additional, Chmielowski, B., additional, Rabinowits, G., additional, Terheyden, P., additional, Brownell, I., additional, Zwiener, I., additional, Bajars, M., additional, Hennessy, M., additional, and Kaufman, H.L., additional
Published: 2017
Full Text: View/download PDF

7. 4100 ORAL Radiation Therapy in Childhood Low Grade Glioma (LGG) – a Subgroup Analysis Within the Scope of the German Multicenter Treatment Study HIT-LGG 1996

Author: Müller, K., primary, Klagges, S., additional, Pietsch, T., additional, Warmuth-Metz, M., additional, Meyer, F.M., additional, Gnekow, A., additional, Voges, J., additional, Nikkhah, G., additional, Zwiener, I., additional, and Kortmann, R.D., additional
Published: 2011
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results